3. Use; Regulatory
(a) The Product is sold for use to treat COVID-19 patients during and potentially following the COVID19 pandemic (as declared by the WHO). UK agrees to ensure that Product shall not be re-sold, exported or used for any other purpose outside of the Territory [United Kingdom], save that UK may donate, re-sell or export Product to the Crown Dependencies and UK Overseas Territories, being those territories listed in Annex G and UK shall be responsible for obtaining all applicable Regulatory Licences and Marketing Approvals for such re sales and exports (“Re-Sold Product“). By way of exception to the foregoing, UK may provide Product which would otherwise be wasted or destroyed as being surplus to UK’s requirements on a not-for-profit basis to any other country or person (any such Product being “Donated Product“) provided that the UK shall be responsible for obtaining all applicable Regulatory Licences and Marketing Approvals for such re-sales and exports.